NDC properties for "2 ML Halaven 0.5 MG/ML Injection" (RxCUI 1045460)
About this data
The tables show NDC propoerties for 2 ML Halaven 0.5 MG/ML Injection with the RxCUI 1045460
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for 2 ML Halaven 0.5 MG/ML Injection (RxCUI 1045460)
| MMSL_CODE | BD26641 |
|---|---|
| NDA | NDA201532 |
| RxCUI | 1045460 |
| SPL_SET_ID | 31ce4750-ded5-4a0b-95e9-f229fa6bc822 |
| SPL_SET_ID | 8fc8fe1d-59fe-4e43-a95c-e7aa13422cd6 |
| Prescribable Synonym | Halaven 1 MG in 2 ML Injection |
| RXNAV_STR | Halaven 1 MG per 2 ML Injection |
| RxNorm Name | 2 ML eribulin mesylate 0.5 MG/ML Injection [Halaven] |
| RxNorm Synonym | 2 ML Halaven 0.5 MG/ML Injection |
| RxNorm Synonym | Halaven 1 MG per 2 ML Injection |
| Tallman Synonym | 2 ML eriBULin mesylate 0.5 MG/ML Injection [Halaven] |
| Related queries | Interactions (for RxCUI 1045460) |
NDC Properties
NDC Item 43624000201
| NDC 9 | 43624-002 |
|---|---|
| NDC 10 | 43624-002-01 |
| NDC Item | 43624000201 |
| Packaging | 100 TRAY in 1 BOX, UNIT-DOSE (43624-002-01) / 3 mL in 1 TRAY |
| COLORTEXT | white(clear, colorless, sterile solution for intravenous administration) |
| Color | C48325 __ |
| FDA SPL set id | 825870 |
| Labeler | BSP Pharmaceuticals SpA |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2017-04-21 |
| Marketing status | ACTIVE |
| NDA | NDA201532 |
| Related queries | Properties for NDC 9 43624-002 |
NDC Item 62856038901
| NDC 9 | 62856-389 |
|---|---|
| NDC 10 | 62856-389-01 |
| NDC Item | 62856038901 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (62856-389-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| FDA SPL set id | 831703 |
| Labeler | Eisai Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-11-15 |
| Marketing status | ACTIVE |
| NDA | NDA201532 |
| Related queries | Properties for NDC 9 62856-389 |
NDC Item 43624000201
| NDC 9 | 43624-002 |
|---|---|
| NDC 10 | 43624-002-01 |
| NDC Item | 43624000201 |
| Packaging | 100 TRAY in 1 BOX, UNIT-DOSE (43624-002-01) / 3 mL in 1 TRAY |
| COLORTEXT | white(clear, colorless, sterile solution for intravenous administration) |
| Color | C48325 __ |
| FDA SPL set id | 825870 |
| Labeler | BSP Pharmaceuticals SpA |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2017-04-21 |
| Marketing status | ACTIVE |
| NDA | NDA201532 |
| Related queries | Properties for NDC 9 43624-002 |
NDC Item 62856038901
| NDC 9 | 62856-389 |
|---|---|
| NDC 10 | 62856-389-01 |
| NDC Item | 62856038901 |
| Packaging | 1 VIAL, SINGLE-DOSE in 1 CARTON (62856-389-01) / 2 mL in 1 VIAL, SINGLE-DOSE |
| FDA SPL set id | 831703 |
| Labeler | Eisai Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-11-15 |
| Marketing status | ACTIVE |
| NDA | NDA201532 |
| Related queries | Properties for NDC 9 62856-389 |